Actinomycetes-mediated biogenic synthesis of metal nanoparticles and their antimicrobial activities are well documented. Actinomycetes facilitate both intracellular and extracellular metal nanoparticles synthesis and are efficient candidates for the production of polydispersed, stable and ultra-small size metal nanoparticles. Secondary metabolites and new chemical entities derived from Actinomycetes have not been extensively studied for the synthesis of metal/metal oxide nanoparticles. The present review focuses on biogenic synthesis of metal nanoparticles from Actinomycetes and the scope for exploring Actinomycetesderived compounds (enzymes, organics acids and bioactive compounds) as metal and metal oxide reducing agents for the synthesis of desired nanoparticles. This review also focuses on challenges faced in the applications of nanoparticles and the methods to synthesize biogenic metal nanoparticles with desired physiochemical properties such as ultra-small size, large surface to mass ratio, high reactivity etc. Methods to evade their toxicity and unique interactions with biological systems to improve their chance as an alternative therapeutic agent in medical and pharmaceutical industry are also discussed.
Introduction
Nanoparticles have attracted great attention in the recent past due to their fascinating properties. Nanoparticles offer advantages such as high-surface area, increased reactivity, surface plasmon resonance (SPR), enhanced Rayleigh scattering and surface enhanced Raman scattering (SERS) over their bulk material (Daniel and Astruc 2004; Kim et al. 2007) . Nanoparticles are widely used in varied applications such as drug delivery, nanoantibiotics, pharmaceutical nanoengineering, catalysis, sensor development, electronics and related fields (Chau et al. 2007) . The application of nanoparticles is influenced by their size, stability, shape and dispersive nature (Narayanan and Sakthivel 2010) . Nanotechnology offers us the opportunity to synthesize nanoparticles of desired characteristics so as to facilitate their use in various applications. Nanoparticles can be synthesized using two approaches namely top-down approach and the bottomup approach (Fendler 1998 ). In the top-down approach, bulk materials are broken down to nano-sized materials and in the bottom-up approach atoms and molecules are assembled to molecular structures in nanometer range. The chemical and biological methods use the bottom-up approach for the synthesis of nanoparticles (Pattekari et al. 2011) . Chemicals such as reducing agents, organic solvents and nonbiodegradable stabilizing agents are also used to synthesize nanoparticles. Though these methods are very popular in the synthesis of nanoparticles, the use of hazardous chemicals limits their use in medical and clinical fields (Li et al. 2011) . Another challenge is to synthesize monodispersed nanoparticles with different shape and size. The high cost involved in the physical and chemical methods also contributes to the search of alternative methods to synthesize nanoparticles (Ingle et al. 2009 ).
Biosynthesis of nanoparticles involving biological system is a rapid, clean, simple, nontoxic, inexpensive and eco-friendly technology. Biosynthesis of nanoparticles is used to obtain high range of chemical composition, size/shape, high monodispersity and large-scale production. Biogenic nanoparticles are advantageous in the fact that they are water soluble and biocompatible. Synthesis of nanoparticles using micro-organisms, enzymes and plant extracts has been suggested as possible biological methods to synthesize nanoparticles (Song and Kim 2008) . Biologically synthesized nanoparticles have proved to be more efficient than the traditionally synthesized nanoparticles. The proteins present in the biological source act in a synergistic way by capping the nanoparticles thereby increasing their efficiency . Among biological system, microbes owing to their diversity emerge as a promising option for nanoparticle synthesis (Płaza et al. 2014) . Biosorption, bioaccumulation, biodetoxification and biomineralization of metals by micro-organisms also make them a suitable biological source to synthesize nanoparticles (Dickson 1999) . A few microbes have the ability to selectively reduce certain metal ions by electron transfer. An example is the hydroquinone released by certain micro-organisms which can reduce ions to nanoparticles (Baker and Tatum 1998) . The nanoparticle biosynthetic process is controlled by the biochemical and the genetic nature of the microbe that is used for the biosynthesis (Naveen et al. 2010) . Bacteria can be easily handled and manipulated and this makes it an easier choice to design-specific nanoparticles based on their shape, size and their application (Zonooz and Salouti 2011) .
Synthesis of nanoparticles using bacteria, yeast and fungi
Many successful attempts have been made in the synthesis of nanoparticles using bacteria, fungi and yeast. Nanoscale gold particles are readily precipitated within bacteria when they are incubated with Au 3+ ions (Beveridge and Murray 1980) . The environment from which the microorganism was isolated influences the formation nanoparticles. An example would be Pseudomonas stutzeri AG259 isolated from silver mine which when placed in a solution of AgNO 3 was able to reduce Ag + ions and form silver nanoparticles within the periplasmic space of the bacteria (Klaus-Joerger et al. 2001) . Synthesis of gold and silver nanoparticles was reported within lactic acid bacteria present in buttermilk after exposure to corresponding metal ions (Nair and Pradeep 2002) . Other bacteria such as Pseudomonas aeruginosa, Morganella sp., Bacillus subtilis, Bacillus licheniformis, Rhodopseudomonas capsulate and Brevibacterium casei mediate intracellular and extracellular synthesis of nanoparticles (Saifuddin et al. 2009; Kiran et al. 2010; Vaidyanathan et al. 2010; Hazra et al. 2013) . It would be interesting to investigate the potential of eukaryotes to synthesize nanoparticles as their genetic makeup and characteristics vary from prokaryotes which would result in nanoparticles with fascinating characteristics and applications. Few genera of fungi have been studied for their synthesis of nanoparticles and it was observed that they are good candidates for producing gold and silver nanoparticles (Mukherjee et al. 2001 (Mukherjee et al. , 2002 . Actinomycetes are micro-organisms which share important characteristics of fungi and prokaryotes such as bacteria and are known for their ability to produce secondary metabolites with varied biological activities (Vimal et al. 2009 ).
Synthesis of biogenic nanoparticles from Actinomycetes
Actinomycetes are capable of synthesizing intracellular and extracellular nanoparticles. Intracellular synthesis occurs on the surface of the mycelia due to the electrostatic binding of Ag + ions to the negatively charged carboxylate groups in the enzyme present on the cell wall of mycelia. The Ag + ions are then reduced by the enzymes in the cell wall forming silver nuclei. The accumulation of the silver nuclei leads to formation of nanoscale silver particles (Sunitha et al. 2013) . Novel alkalotolerant Actinomycetes, Rhodococcus sp. was used to synthesize gold nanoparticles. The results from transmission electron microscopic (TEM) image showed the presence of nanoparticles on the walls of the Actinomycetes confirming the intracellular synthesis of gold nanoparticles (Ahmad et al. 2003) . Intracellular synthesis of silver nanoparticles using Rhodococcus NCIM 2891 was reported (Otari et al. 2012) . Wet biomass of Streptomyces hygroscopicus was exposed to HAuCl 4 and at 72 h the yellow coloured biomass turned pink indicating the formation of extracellular gold nanoparticles (Waghmare et al. 2014) . Streptomyces sp. HBUM171191 was reported to produce silver, manganese and zinc nanoparticles when the wet biomass was exposed to the corresponding metal solutions. The colour change of the biomass from light yellow to brown, dark yellow and dark yellow indicates the formation of silver, manganese and zinc nanoparticles (Waghmare et al. 2011) .
Extracellular synthesis of nanoparticles can be attributed to the enzymes that are involved in nitrogen cycle. They may be responsible for the electron shuttle enzymatic metal reduction process (Karthik et al. 2014) . The a-NADH-dependent nitrate reductase plays an important role in the reduction of Ag + ions to silver nuclei. Actinomycetes mediated the extracellular synthesis of nanoparticles using Streptomyces glaucus 71MD (Tsibakhashvili et al. 2011) . Pure culture of Streptomyces sp. ERI-3 reduced colourless silver nitrate solution to a reddish brown colour within 12 h (Zonooz and Salouti 2011) indicating the formation of silver nanoparticles.
Metal and metal oxide nanoparticles from Actinomycetes as nanoantibiotics

Antibacterial activity of nanoparticles from Actinomycetes
Silver has been used as antimicrobial agent since ancient times. Silver is also known for its catalytic activity, chemical stability and good conductivity. Silver in minute quantities is not toxic to human health. These properties make silver an excellent choice to synthesize silver nanoparticles for biomedical applications. Actinomycetes are well known for their ability to produce secondary metabolites/new chemical entities, which serve as antibiotics. Since Actinomycetes are primary source for antibacterial substances, there are numerous reports of Actinomycetes-mediated metal and metal oxide nanoparticle synthesis and their antimicrobial activity. Silver nanoparticles produced from Actinomycetes have been shown to possess significant antibacterial activity. Silver nanoparticles synthesized using Streptomyces sp. BDU-KAS10, showed 16, 15 and 13 mm zones of inhibition against Staphylococcus aureus, P. aeruginosa and Bacillus cereus respectively (Sivalingam et al. 2012) . Silver nanoparticles were synthesized extracellularly from Streptomyces rochei using 10 À3 AgNO 3 and 10 À4 AgNO 3 and were used to evaluate the antibacterial activity. Zones of inhibition of 28 mm, 22 mm, 21 mm, 25 mm and 31 mm against P. aeruginosa, Escherichia coli, Klebsiella pneumoniae, Enterococcus faecalis and S. aureus were reported (Selvakumar et al. 2012) . Synthesis of silver nanoparticles using Streptomyces sp. & Rhodococcus sp. and their antibacterial potential with the zone inhibition of 26 mm against Pseudomonas aeruginosa followed by S. aureus (23 mm), Klebsiella Pneumoniae (21 mm) and E. coli (19 mm) was reported (Sukanya et al. 2013) . Extracellular silver nanoparticles synthesized from Streptomyces parvulus SSNP11 exhibited zone inhibition of 30, 26, 21 and 26 mm against Bacillus subtilis, Salmonella typhi, Pseudomonas putida and Klebsiella pneumoniae respectively (Prakasham et al. 2014) . Intracellular gold nanoparticle synthesized from Streptomyces viridogens HM10 showed 14 and 16 mm zones of inhibition against S. aureus and E. coli (Balagurunathan et al. 2011) . Antibacterial activity of metal nanoparticles from Actinomycetes species is given in Table 1 .
Antifungal activity of nanoparticles from Actinomycetes
The biologically synthesized silver nanoparticles using Streptomyces sp. JAR1 inhibited Fusarium sp. and Aspergillus terrus JAS1 with zones of inhibition of 21 and 16 mm respectively for 100 ll of nanoparticles (Chauhan et al. 2013) . Silver nanoparticle synthesized from Streptomyces sp. VITBT7 showed selective inhibition against Aspergillus fumigatus (MTCC 3002) and Aspergillus niger (MTCC 1344) with 20 and 22 mm which were better than the activity of the cell free supernatant (Subashini and Kannabiran 2013) . Silver nanoparticles synthesized from Streptomyces sp. VITSTK7 showed antifungal index of 75% against A. fumigatus, 67% against A. niger and 62% against Aspergillus flavus . Silver nanoparticles synthesized using Streptomyces sp.VITPK1 showed potential anticandidal activity against Candida albicans, Candida tropicalis and Candida krusei with zones of inhibition of 20, 18 and 16 mm respectively (Sanjenbam et al. 2014) . Gold nanoparticles synthesized using Streptomyces sp. VITDDK3 exhibited antifungal activities against Microphyton gypseum and Tricophyton rubrum with zones of inhibition of 10 and 13 mm respectively (Gopal et al. 2013) . Nanoparticles were also found to be potentially active against various human pathogenic 
Antiparasitic activity of nanoparticles from Actinomycetes
Silver nanoparticles synthesized from Actinomycetes (Streptomyces sp.), have also been reported to possess antiparasitic activity against Rhipicephalus microplus and Haemaphysalis bispinosa (Karthik et al. 2014) .
Biological applications of nanoparticles from Actinomycetes
Antioxidants neutralize free radicals thereby protecting cell damage. Metal and metal oxide nanoparticles are effective free radical scavengers and thus play an important role in biomedical applications (Hamasaki et al. 2008) . Free radicals initiate lipid peroxidation which is the oxidative degradation of lipids which incurs cell damage. Gold nanoparticles synthesized from Streptomyces sp. NK52 exhibited 47% inhibition of lipid peroxidation (Prakash et al. 2013) . Silver nanoparticles synthesized from Nocardiopsis sp. MBRC-1 showed cytotoxic activity against human cervical cancer cell line and it caused 50% inhibition to cell viability at 200 lg ml À1 of the nanoparticle (Manivasagan et al. 2013) . Gold nanoparticles produced by marine Nocardiopsis sp. MBRC-48 showed better reducing potential than standard ascorbic acid. It exhibited 69% of DPPH free radical scavenging activity at 300 lg ml À1 (Manivasagan et al. 2015) .
Nanoparticles synthesized from Actinomycetes having antimicrobial properties are used in fabric industry. Copper and zinc nanoparticles synthesized using Streptomyces sp. were coated on to 100% cotton fabric by paddry-cure-method. The processed fabric was placed on to a bacteriostasis agar plate swabbed with the bacterial inoculums. Copper nanoparticles synthesized showed a zone of bacteriostasis of 30 and 27 mm after 24 h for S. aureus and E. coli respectively. The synthesized zinc nanoparticles showed a zone of bacteriostasis of 24 mm and 21 mm after 24 h for S. aureus and E. coli respectively. These fabrics can be used in hospitals to prevent or minimize infection (Usha et al. 2010) . Silver nanoparticles (25 lg) synthesized from Streptomyces sp. showed 22 mm zone of inhibition against extended-spectrum beta-lactamases (ESBL) pathogen Klebsiella pneumoniae (ATCC 700603) (Subashini et al. 2014) . Gold nanoparticles synthesized from Streptomyces sp LK-3 were used to treat Plasmodium berghei ANKA (PbA) infected mice and it was observed that the survivability increased up to 85% when compared to the control whose survivability was 50% on 8 days postinfection (Karthik et al. 2013) . Table 2 summarizes other applications (excluding antibacterial activity) of nanoparticles from Actinomycetes.
Synthesis of biogenic nanoparticles from Actinomycetes-derived compounds
Very few reports are available on the synthesis of biogenic nanoparticles from Actinomycetes-derived compounds. A blue pigment, actinorhodin produced by Streptomyces coelicolor was separated from the cells by centrifugation and was used to synthesize silver nanoparticles by photoirradiation method. The synthesized nanoparticle was tested for antibacterial activity against Methicillin-resistant S. aureus (MRSA) (Manikprabhu and Lingappa 2013) . Gold and silver nanoparticles were produced using methyl esters of myristate, palmitate and stearate (thermostable glycolipid) extracted from Gordonia amicalis HS-11, cultivated on a medium containing n-hexadecane as the sole source of carbon. The glycolipid-mediated synthesized gold and silver nanoparticles exhibited 89Á8 and 94Á85% hydroxyl radical scavenging activity respectively. The gold and silver nanoparticles mediated by the purified glycolipid exhibited 74 and 67Á25% nitric oxide radical scavenging activity respectively (Sowani et al. 2016) . The increase in efficiency of nanoparticles synthesized using Actinomycetes-derived compound is evident from the above reports. Each Actinomycetes strain had the genetic potential to synthesis 10-20 secondary metabolites (Lam 2006) . The metal and metal oxide reducing potential of Actinomycetes-derived compounds for biogenic synthesis of nanoparticles and the possible mechanism involved in the synthesis need to be explored. Such nanoparticles would have better bioactive efficiency than conventional nanoparticles.
Challenges of using metal and metal oxide nanoparticles
Even though biogenic NPs find extensive applications in various fields, they have few shortcomings which prevent their use in medical and other related applications. Effective stabilization is necessary to prevent agglomeration of nanoparticles due to the high-surface energy and protect the properties of the synthesized nanoparticles. Biodistribution of nanoparticle is affected by interaction with proteins through a process called opsonization and these alter the properties of the nanoparticles (Sanvicens and Marco 2008) . Mononuclear phagocyte system also called Letters in Applied Microbiology 64, 401--408 © 2017 The Society for Applied Microbiology as reticuloendothelial system (RES) composed of monocytes and macrophages also interacts with nanoparticles. Several approaches have been tried to evade the unwanted interactions of NPs during delivery. One such approach is coating the nanoparticles with polymers. Coating of nanoparticles using polyethylene glycol (PEG) minimizes unwanted recognition and thereby increases the circulation half-life of nanoparticles (Owens and Peppas 2006) . Multi-walled carbon nanotubules (MWCNT) when coated with ammonium/chelator functional group evade uptake by RES (Singh et al. 2006) . Water soluble, thiol-stabilized gold nanoparticles were synthesized using monohydroxy (1-mercaptoundec-11-yl) tetraethylene glycol for better medical applications. The hydrophilic tetraethylene glycol group makes the nanoparticles water soluble and the hydrophobic carbon chain confers stability to the nanoparticle (Li et al. 2002) . Water solubility of the nanoparticles increases its biocompatibility. The toxic effect of nanoparticles has to be taken into account when they are used for in vivo applications. Nanotoxicity is related to (i) the possible release of (toxic) ions from metallic nanoparticles and (ii) the oxidative stress due to the intrinsic characteristics of the nanoparticle (morphology, surface charge, size and chemical surface composition) (Seabra and Duran 2015) . None of the nanoparticles synthesized using Actinomycetes were tested extensively for toxicity. Element-specific toxicity due to the core metal or metal oxide and at certain instances toxicity caused by surface coating contributes to nanotoxicity of nanoparticles. Other desired property would be the specificity which can be achieved by adding aptamers, peptide etc. which recognizes a prostate-specific membrane antigen (Farokhzad et al. 2006) . The mechanism of interaction between the nanoparticle and the cells is not clearly understood and this would help the researchers to synthesize desired metal and metal oxide nanoparticles with better efficiency. Use of magnetic nanoparticles and quantum dots facilitates real-time imaging and biodistribution of nanoparticles (Derfus et al. 2007) .
The main challenges related to green synthesis of NPs can be summarized as (i) limitations related to the scaling up the syntheses processes; (ii) the reproducibility of the biogenic processes needs to be improved; (iii) the mechanism of nanoparticle formation is not completely elucidated; (iv) the control over nanoparticle size and distribution needs to be enhanced; (v) mechanism of action metal/metal oxide NPs on targets needs to be studied. In addition, the potential toxic effects of biogenically synthesized nanoparticles need to be studied further. Therefore, there is a need for further studies on biogenic synthesis of metal and metal oxide nanoparticles from Actinomycetes/Actinomycetesderived secondary metabolites for stability, toxicity, specific size, shape and composition to make it as effective bioactive nanoparticles for therapeutic applications.
Conclusion
New therapeutic agents are the need of the hour as microbial pathogens develop resistance to the available antimicrobial agents. Actinomycetes have been extensively Silver, gold 5-25/spherical Free radical scavenging activity Sowani et al. (2016) studied for their ability to produce secondary metabolites with varied biological applications. Biogenic synthesis of nanoparticles mediated by Actinomycetes has great scope for developing nanoantimicrobials and nanoantibiotics which could be used as alternative therapeutic agents. Though there are several reports of biogenic nanoparticle synthesis from Actinomycetes, studies on synthesis of metal nanoparticles using Actinomycetes-derived bioactive compounds are scanty and needs to be studied further. Targeted drug delivery needs to be improved in such a way they distinguish microbes and infectious cells from healthy cells. Biocompatible nanoparticles should be developed so as to use them in medical and pharmaceutical fields. The fate of biogenically synthesized nanoparticles on human tissues needs to be studied further. All these factors should be taken into account while synthesizing biogenic nanoparticles for in vivo use as therapeutic agents.
